Life Sciences Investing

Sixth Street has led an $830 million growth equity investment into Caris Life Sciences, according to a news release.

Caris, based in Irving, Texas, develops molecular profiling assays for oncology that scan DNA, RNA and proteins to reveal a molecular blueprint intended to help physicians and patients make more precise and personalized cancer

The Carlyle Group has announced it has agreed to acquire Unchained Labs for $435 million.

Unchained Labs, based in Pleasanton, Calif., is a producer of life sciences tools. Founded in 2015, the company focuses on solving problems for biologics and gene therapy researchers.

The Carlyle Group, with its U.S. headquarters in Washington, D.C.,

OrbiMed has announced it has raised $3.5 billion in commitments for its latest private investment funds.

The investments are broken down as follows:

  • $1.5 billion for OrbiMed Private Investments VIII, which invests primarily in North America and Europe with a focus on biotechnology, medical device and diagnostics companies
  • $800 million for OrbiMed Asia Partners IV,

NovaQuest Private Equity has announced it has acquired CoreRx.

CoreRx, based in Clearwater, Fla., is a contract development and manufacturing organization that serves small to mid-sized pharmaceutical and biotech organizations. Founded in 2006, the company offers preformulation, formulation, analytical and stability, clinical manufacturing, commercial manufacturing and packaging services.

NovaQuest Private Equity is the private

Frazier Healthcare Partners has acquired a 50% stake in CSafe Global from Thomas H. Lee Partners (THL), according to a news release.

CSafe Global, based in Dayton, Ohio, is a provider of cold chain shipping solutions to global pharmaceutical and life sciences companies.

Frazier Healthcare Partners, based in Seattle, is a provider

Blackstone has announced the closing of its inaugural life sciences fund with $4.6 billion of total capital commitments.

The company stated that the fund, Blackstone Life Sciences V, is the largest life sciences private fund raised to date.

Blackstone Life Sciences has three main investment strategies: collaborations with established companies, late-stage product financings, and growth

Maravai LifeSciences, a portfolio company of GTCR, has announced it has acquired MockV Solutions.

Maravai, based in San Diego, is a provider of life science reagents and services to researchers and biotech partners. The company focuses on DNA and RNA synthesis, bioprocess impurity testing and research immunohistochemistry and immunofluorescence.

MockV, based in Rockville,

The Blackstone Group has announced the closing of its acquisition of Clarus. The business will now operate as Blackstone Life Sciences.

Blackstone indicated that its new private investment platform will invest across the lifecycle of companies and products within life sciences sectors.

Historical funds will retain the Clarus name.

Blackstone had previously announced its acquisition

Avista Capital Partners will acquire Miraca Life Sciences from Miraca Holdings, according to a news release.

Miraca Life Sciences, based in Irving, Texas, is a national, independent anatomic pathology lab providing subspecialty anatomic pathology services in the fields of gastroenterology, dermatology, hematology, breast health and urology.

Avista, headquartered in New York, a